Cargando…
Suppressor of cytokine signalling-2 limits IGF1R-mediated regulation of epithelial–mesenchymal transition in lung adenocarcinoma
Non-small cell lung cancer (NSCLC), including adenocarcinoma and squamous cell carcinoma, is the leading cause of death from lung malignancies and has a poor prognosis due to metastasis. Suppressor of cytokine signalling-2 (SOCS2), a feedback inhibitor of cytokine signalling, has been shown to be in...
Autores principales: | Zhou, Yue, Zhang, Zhilei, Wang, Ning, Chen, Jizheng, Zhang, Xu, Guo, Min, John Zhong, Li, Wang, Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861121/ https://www.ncbi.nlm.nih.gov/pubmed/29559623 http://dx.doi.org/10.1038/s41419-018-0457-5 |
Ejemplares similares
-
IGF-1 induces the epithelial-mesenchymal transition via Stat5 in hepatocellular carcinoma
por: Zhao, Chuanzong, et al.
Publicado: (2017) -
IGF-IR signaling in epithelial to mesenchymal transition and targeting IGF-IR therapy: overview and new insights
por: Li, Heming, et al.
Publicado: (2017) -
IGF-1 Promotes Epithelial-Mesenchymal Transition of Lens Epithelial Cells That Is Conferred by miR-3666 Loss
por: Wang, Chao, et al.
Publicado: (2022) -
NRBP2 Functions as a Tumor Suppressor and Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer
por: Li, Zhiyu, et al.
Publicado: (2021) -
Epithelial-to-Mesenchymal Transition in Pancreatic Adenocarcinoma
por: Cano, Carla, et al.
Publicado: (2010)